Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Advisory committee recommends approval of Photofrin for early-stage NSCLC

Sep. 19, 1997

Natural chemopreventive agent evaluated in rodent tumorigenesis models

Sep. 19, 1997

Oxford GlycoSciences' OGT-719 enters clinical testing

Sep. 18, 1997

3-D database search at Schering-Plough leads to potent, selective FPT inhibitors

Sep. 18, 1997

New anthraquinone interacting with telomeric G-quadruplex DNA

Sep. 18, 1997

Genentech discovers new cytokine inducing apoptosis

Sep. 17, 1997

Pharmacia & Upjohn discovers potent camptothecin analogues

Sep. 17, 1997

Preliminary results from phase II/III Sensamide study

Sep. 16, 1997

NCI evaluates stability of SarCNU

Sep. 16, 1997

Cytel and Searle to collaborate on cancer therapies

Sep. 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...